Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.

Size: px
Start display at page:

Download "Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved."

Transcription

1

2 Heart Disease and Stroke Statistics 21 Update

3 Questions on statistics? Audio-visual questions? Please keep the red wave and logo attached to these slides.

4 Deaths in Thousands Years Males Females CVD disease mortality trends for males and females (United States: ). Source: NCHS and NHLBI.

5 Per 1, Population Coronary Heart Disease Stroke Lung Cancer Breast Cancer White Females Black Females Age-adjusted death rates for CHD,, stroke, lung and breast for white and black females (United States: 26). Source: NCHS.

6 1, Deaths in Thousands Years Deaths from diseases of the heart (United States: 19 26) Note: See Glossary for an explanation of Diseases of the Heart. Source: NCHS.

7 12 Deaths in Thousands Years Deaths from cardiovascular disease (United States: 19 26). Source: Source: NCHS and NHLBI.

8 Discharges in Millions Years Hospital discharges for cardiovascular diseases. (United States: ). 26). Note: Hospital discharges include people discharged alive, dead and status unknown. Source: NCHS and NHLBI.

9 Coronary Heart Disease Stroke HF* High Blood Pressure Diseases of the Arteries Other Percentage breakdown of deaths from cardiovascular diseases (United States: 26) * - Not a true underlying cause. Source: NCHS.

10 Percent of Population Men Women Prevalence of CVD in adults age 2 and older by age and sex (NHANES 23-26). Source: NCHS and NHLBI. These data include coronary heart disease, heart failure, stroke and hypertension.

11 Per 1, Person Years Age Men Women Incidence of CVD* by age and sex. (FHS,, ). Source: NHLBI. * Includes CHD, HF,, stroke or intermittent claudication.. Does not include hypertension alone.

12 Deaths in Thousands 1, < Total Ages CVD Cancer CVD deaths vs. cancer deaths by age. (United States: 26). Source: NCHS.

13 Deaths 9, 8, 7, 6, 5, 4, 3, 2, 1, Alzheimer CLRD Cancer All Other CVD Stroke Heart Disease All Ages < CVD and other major causes of death: both sexes. (United States: 26). Source: NCHS and NHLBI.

14 Deaths 45, 4, 35, 3, 25, 2, 15, 1, 5, CLRD Accidents Cancer All Other CVD Stroke Heart Disease All Ages < CVD and other major causes of death: males (United States: 26). Source: NCHS and NHLBI.

15 5, Deaths 4, 3, 2, 1, Alzheimer CLRD Cancer All Other CVD Stroke Heart Disease All Ages < CVD and other major causes of death: females (United States: 26). Source: NCHS and NHLBI.

16 5, 4, 398, ,79 Deaths 3, 2, 29,69 269,819 1, 78,941 59,26 36,6 65,323 51,281 42,658 A B C D E A B D F C Males Females A CVD (I-I99; I99; Q2-Q28) Q28) B Cancer C Accidents D Chronic Lower Respiratory Diseases E Diabetes Mellitus F Alzheimer s s Disease CVD and other major causes of death for all males and females (United States: 26). Source: NCHS and NHLBI.

17 Percent of Total Deaths A B C D E A B D F C Males Females A CVD (I-I99; I99; Q2-28) 28) B Cancer C Accidents D Chronic Lower Respiratory Diseases E Diabetes Mellitus F Alzheimer s s Disease CVD and other major causes of death for white males and females (United States: 26). Source: NCHS and NHLBI.

18 Percent of Total Deaths A B C D E A B E F C Males Females A CVD (I-I99; I99; Q2-Q28) Q28) B Cancer C Accidents D Assault (Homicide) E Diabetes Mellitus F Nephritis, Nephrotic Syndrome and Nephrosis CVD and other major causes of death for black males and females. (United States: 26). Source: NCHS and NHLBI.

19 Percent of Total Deaths A B C D E A B D C F Males Females A CVD (I-I99) I99) B Cancer C Accidents D Diabetes Mellitus E Assault (Homicide) F CLRD CVD and other major causes of death for Hispanic or Latino males and females (United States: 26). Source: NCHS and NHLBI.

20 Percent of Total Deaths A B C D E A B C E F Males Females A CVD (I-I99) I99) B Cancer C Accidents D Chronic Lower Respiratory Diseases E Diabetes Mellitus F Influenza and Pneumonia CVD and other major causes of death for Asian or Pacific Islander males and females (United States: 26). Source: NCHS and NHLBI.

21 Percent of Total Deaths A B C D E A B C D F Males Females A CVD (I-I99) I99) B Cancer C Accidents D Diabetes Mellitus E Chronic Liver Disease and Cirrhosis F Chronic Lower Respiratory Diseases CVD and other major causes of death for American Indian or Alaska Native males and females (United States: 26). Source: NCHS and NHLBI.

22 Cardiovascular Obstetrical V Digestive System Respiratory System External: Injuries, etc Mental Genitourinary System Musculoskeletal System Endocrine System Neoplasms Hospital Discharges (in millions) for the 1 Leading diagnostic Groups (United States: 26). Source: NHDS/NCHS and NHLBI.

23 Estimated 1-Year Rate% A B C D Men Women Estimated 1-Year CVD risk in 5 to 54-year year-old adults according to levels of various risk factors (Framingham Heart Study). Source: D Agostino D et al., Circulation. 28;117: A B C D Age HDL Cholesterol, mg/dl Total Cholesterol (mg/dl dl) ) Systolic BP mm/hg, no treat Smoker No No No Yes Diabetes No No Yes Yes mm Hg = millimeters of mercury. mg/dl = milligrams per deciliter of blood

24 Proportion (%) With Detectable Calcium Men Women White Black Prevalence (%) of Coronary Calcium: US Adults Ages Years (CARDIA Study). Source: Loria et al., JACC.. 27;49(2):

25 Proportion (%) With Detectable Calcium White Black Hispanic Chinese Men Women Prevalence (%) of Coronary Calcium: US Adults Ages Years (The MESA Study). Source: Bild et al., Circulation. 25;111:

26 Hazard Ratio (HR) Compared to CAC= >3 Major CHD Events Any CHD Events Hazard Ratios for CHD Events Associated With Coronary Calcium Scores: US Adults Ages Years (Reference Group CAC=) Source: Detrano et al., NEJM.. 28;358(13):

27 Hazard Ratio (HR) Compared to CAC= FRS <1% FRS 1-15% FRS 16-2% CAC >2% CAC CAC 1-1 CAC 11-3 CAC >3 Hazard Ratios for CHD Events Associated With Coronary Calcium Scores: US Adults (Reference Group CAC= and Framingham Risk Scores <1%) Source: Greenland et al., JAMA.. 24;291(2):

28 Mean Carotid IMT (mm) Common Carotid Carotid Bulb Internal Carotid White Women Black Women White Men Black Men Mean Values of Carotid IMT for Different Carotid Artery Segments in Younger Adults by Race and Sex (Bogalusa Heart Study) Source: Urbina et al., Am J Card. 22;9(9):

29 Mean Carotid IMT (mm) Common Carotid Internal Carotid White Black Hispanic Chinese Mean Values of Carotid IMT for Different Carotid Artery Segments in Older Adults by Race (MESA Heart Study) Source: Manolio et al., Atherosclerosis 28;197(1):

30 Estimated Estimated 1-Year 1-Year Rate Rate (%) (%) A B C D Blood Pressure (mm Hg) 12/8 14/9 14/9 14/9 Total Cholesterol (mg/dl) HDL Cholesterol (mg/dl) Diabetes 5 Cigarettes 5 Men Women No No No No Yes No mm Hg = millimeters of mercury. mg/dl = milligrams per deciliter of blood Estimated 1-Year CHD risk in 55-year year-old adults according to levels of various risk factors (Framingham Heart Study). Source: Wilson et al., Circulation. 1998;97: A B C D Yes Yes 27 27

31 New and Recurrent MI or Fatal CHD Ages Men Women Annual number of U.S. Adults having diagnosed heart attack by age and sex (ARIC:: and CHS: ). Source: NHLBI. Includes MI and fatal CHD but not silent MI s.

32 Percent of Population Men Women Prevalence of CHD by age and sex (NHANES :23-26) 26). Source: Source: NCHS and NHLBI.

33 Prevalence (%) All Women Men Prevalence of low CHD risk, overall and by sex, ages (NHANES : ) 26). Source:Personal communication with communication with NHLBI 6/28/7. Low risk is defined as SBP <12 mm Hg and DBP<8 mm Hg; cholesterol < 2 mg/dl and BMI <25 kg/m2 and currently not smoking cigarettes and no prior MI or DM.

34 Per 1, Persons White Men Black Men White Women Black Women Annual rate of first heart attack by age, sex and race. (ARIC Surveillance: ) 24). Source: NHLBI.

35 Per 1, Person Years Incidence of Myocardial Infarction* by Age, Race and Sex. (ARIC Surveillance: ). Source: NHLBI NHLBI. * MI diagnosed by expert committee based on review of hospital records. White Men Black Men White Women Black Women

36 Per 1, Person Years Age Men Women Incidence of Angina Pectoris* by Age and Sex. (FHS:: /23). Source: NHLBI NHLBI. * AP uncomplicated based on physicians interview of patient. Note: Rate for women age considered unreliable.

37 Discharges in Thousands Years Males Females Hospital discharges for coronary heart disease by sex (United States: ). Source: NHDS/NCHS. Note: Hospital discharges include people discharged alive, dead, and status unknown.

38 14 Procedures in Thousands Years Trends in Carotid Endarterectomy Procedures (United States: ). Source: NHDS/NCHS NHDS/NCHS and NHLBI.

39 Percent of Population Men Women Prevalence of stroke by age and sex (NHANES:: 23-26). 26). Source: NCHS and NHLBI.

40 Incidence per per 1, 1, Ischemic Intracerebral hemorrhage Subarachnoid hemorrhage Annual age-adjusted adjusted incidence of first-ever stroke, by race. Inpatient plus out-of of-hospital ascertainment. (GCNKSS:: and 1999). Source: Stroke 25;36;72 White White '93-94 '93-94 White White '99 '99 Black Black '93-94 '93-94 Black Black '99 '99 Source: Stroke 25;36;

41 Per 1, Persons Age s Annual rate of first cerebral infarction by age, sex and race (GCNKSS:: 1999). Source: Unpublished data GCNKSS. Note rates for ages for black males and females and for black males ages 75 and over, are considered unreliable. An estimated 15, people have first cerebral infarctions before age 45. WM WF BM BF

42 Per 1, Persons Ages Annual rate of all first-ever strokes by age, sex and race (GCNKSS:: 1999). Source: GCNKSS unpublished data. Note: rates for ages for black men and women and for black men 75 and over, are considered unreliable. WM WF BM BF

43 Estimated Estimated 1-Year 1-Year Rate Rate (%) (%) Men Men Women Women A B C D E F A B C D E F Systolic BP* Diabetes No No Yes Yes Yes Yes Cigarettes No No No Yes Yes Yes Prior Atrial Fib. No No No No Yes Yes Prior CVD No No No No No Yes *Closest ranges for women are: and Estimated 1-year stroke risk in 55-year year-old adults according to levels of various risk factors (FHS). Source: Wolf et al., Stroke.1991;22:

44 Percent of Population Men Women Prevalence of high blood pressure in Adults age 2 and older, by age and sex (NHANES:: 23-26) 26). Source: NCHS and NHLBI.

45 Percent of Population With Hypertension Awareness Treatment Controlled Total Population NH Whites NH Blacks Mexican Americans Extent of awareness, treatment and control of high blood pressure by race/ethnicity (NHANES : 23-26). 26). Source: NCHS and NHLBI.

46 5 Percent of Population NH White Men NH White Women NH Black Men NH Black Women Mexican American Men Mexican American Women Age-adjusted prevalence trends for high blood pressure in Adults age 2 and older by race/ethnicity, sex and survey (NHANES:: , 94, and 23-6). 6). Source: NCHS and NHLBI.. NH- non-hispanic

47 Percent of Population With Hypertension Awareness Treatment Controlled Extent of Awareness, Treatment and Control of High Blood Pressure by Age (NHANES:: 23-26). 26). Source: NCHS and and NHLBI.

48 Percent of Population With Hypertension Extent of Awareness, Treatment and Control of High Blood Pressure by Race/Ethnicity and Sex (NHANES:: ). Source: NCHS and NHLBI. Awareness Treatment Controlled NH White Men NH White Women NH Black Men NH Black Women Mexican-American Men Mexican-AmericanWomen

49 Percent of Population Men Women Prevalence of heart failure by age and sex (NHANES:: 23-26). 26). Source: NCHS and NHLBI.

50 7 Discharges in Thousands Years Male Female Hospital discharges for heart failure by sex. (United States: ). Source: NHDS/NCHS and NHLBI. Note: Hospital discharges include people discharged alive, dead and status unknown.

51 Per 1, Person Years Age Men Women Incidence of Heart Failure* by age and sex. (FHS:: ). Source: NHLBI. * HF based on physician review of medical records and strict diagnostic criteria.

52 Percent of Population NH Whites NH Blacks Hispanics Males Females Prevalence of students in grades reporting current cigarette smoking by race/ethnicity and sex. (YRBS:27). Source: MMWR. 28;57:SS4. NH non-hispanic.

53 Percent of Population Men NH White Hispanic NH American Indian/Alaska Native Prevalence of current smoking for Adults age 18 and older by race/ethnicity and sex (NHIS:27). Source: MMWR.. 28;57: NH non-hispanic. NH Black NH Asian Women

54 Mean Total Blood Cholesterol White Males Black Males White Females Black Females Mex. Am. Males Mex. Am. Females Trends in mean total serum cholesterol among adolescents ages by race, sex, and survey (NHANES:: , , 94, , 23-4, 4, and 25-6). 6). Source: NCHS and NHLBI

55 Mean Serum Total Cholesterol NH White NH Black Mexican American Trends in mean total serum cholesterol among adults age 2 and older, by race/ethnicity and survey (NHANES : , 94, , and 25-6). 6). Source: NCHS and NHLBI.. NH non-hispanic

56 Percent of Population NH White Males NH White Females NH Black Males NH Black Females MA Males MA Females Trends in the prevalence of total serum cholesterol (2+mg/dL) in adults age 2 and older, by sex, race/ethnicity and survey. (NHANES:: and 25-6) 6) Source: NCHS and NHLBI.. NH non-hispanic. MA Mexican Am

57 Percent of Population Male Female Prevalence of students in grades who met currently recommended levels of physical activity during the past 7 days by race/ ethnicity and a sex (YRBS:: 27). Source: MMWR.. 28;57:No. SS-4. NH non-hispanic. Note: Currently recommended levels is defined as activity that increased their heart rate and made them breathe hard some of the time for a total of at least 6 minutes/day on 5 or more of the 7 days preceding the survey. NH White NH Black Hispanic

58 Percent of Population NH White NH Black Hispanic Other race Prevalence of regular leisure-time physical activity among adults age 18 and older by race/ethnicity, and sex. (BRFSS:: 21 and 25). Source: MMWR,, 27;56:No. 46. NH non-hispanic. Men '1 Women '1 Men '5 Women '5

59 Percent of Population Male Female Prevalence of students in grades who did not meet currently recommended MVPA during the past 7 days by race/ethnicity, and sex. (YRBS:: 27). Source: MMWR (No.SS-4). NH non-hispanic. NH White NH Black Hispanic MMWR 28;57

60 Percent of Population Male Female Prevalence of children ages who attained sufficient MVPA to meet public health recommendations of >6 minutes/day on >5 of 7 days by sex and age. (NHANES:: 23-4). 4). Source: MSSE 28;4:

61 Percent of Population Males Females Prevalence of overweight among students in grades by race/ethnicity and sex (YRBS:: 27). Source: MMWR MMWR : No. SS-4. BMI 95th percentile or higher by age and sex of the CDC 2 growth chart. NH non-hispanic. NH Whites NH Blacks Hispanics

62 Percent of Population Men Women Age-adjusted prevalence of obesity in Adults ages 2-74 by sex and survey. (NHES,, ; 62; NHANES,, , 74, , and 23-26). 26). Source: Health, United States, 28. NCHS. Note: Obesity is defined as a BMI of 3. or higher.

63 Percent of Population Trends in prevalence of overweight among U.S. children and adolescents by age and survey. (NHANES,, , and 23-26). 26). Source: Health, United States, 28. Source: Health, United States, 28. NCHS.

64 Percent of Population Men Women NH Whites NH Blacks Mexican Americans Prevalence of physician-diagnosed diabetes in Adults age 2 and older by race/ethnicity and sex (NHANES:: 23-26). 26). Source: NCHS and NHLBI.. NH non non-hispanic.

65 Percent of Population NH Whites NH Blacks Mexican Americans Less than high school High school More than high school Prevalence of Physician Diagnosed Type 2 diabetes in Adults age 2+ by Race/Ethnicity, and Years of Education (NHANES: 23-26). 26). Source: NCHS and NHLBI. NH non-hispanic.

66 Percent of Population Physician Diagnosed Undiagnosed Physician Diagnosed 23-6 Undiagnosed 23-6 Male Female Trends in diabetes prevalence in adults age 2+ by Sex (NHANES:: and 23-26). 26). Undiagnosed for females considered unreliable. Source: NCHS and NHLBI. NH non-hispanic.

67 Treated and Controled Treated and Uncontroled Not Treated, but Aware Not Treated and Undiagnosed Diabetes Awareness, Treatment and Control (NHANES:: 23-26). 26). Source: NHLBI.

68 23% 36% 62% 2% 3% 1% 4% 51% 5% % 2% 2% 2% 3% Eating and drinking places Retail stores, direct selling Schools and colleges Foods at Home Hotels and motels Recreational places All other foods away from home Figure Total U.S. Food Expenditures Away from Home and At Home, 1977 and 27. Source: United States Department of Agriculture Economic Research Service

69 per capita calories per day Soda/cola Sweetened fruit drinks Alcohol 1% Fruit juice Whole-fat milk Low-fat milk Coffee Tea Figure Per Capita Calories Consumed from Different Beverages by U.S. Adults (age 19 and older), Source: Nationwide Food Consumption Surveys (1965, ) 78) and NHANES ( , 94, ); Duffey & Popkin, Obesity (Silver Spring) 27

70 Fat Carbohydrate Protein Calories percent energy total kcal per day Men Women Figure Age-Adjusted Adjusted Trends in Macronutrients and Total Calories Consumed by U.S. Adults (2-74 years), Source: National Center for Health Statistics. Health, United States 28, With Special Focus on Young Adults. NCHS; ; 29

71 Number of Transplants 2,5 2, 1,5 1, ,363 2,17 2,199 2, Years Trends in Heart Transplants (UNOS: ). Source: United Network for Organ Sharing (UNOS), scientific registry data.

72 Procedures in Thousands Years Catheterizations PCI Pacemakers Bypass Carotid Endarterectomy Trends in Cardiovascular Operations and Procedures (United States: ) 26). Source: NCHS and NHLBI. Note: In-hospital procedures only.

73 Obstetrical Cardiovascular Digestive System Musculoskeletal Female Genital Organs Integumentary System Respiratory System 3-34 Nervous System Urinary System Hemic and Lymphatic Number of Surgical Procedures in the 1 Leading Diagnostic Groups (United States: 26). Source: NHDS/NCHS and NHLBI Millions

74 Cardiovascular Digestive System Mental Nervous System Injury and Poisoning Respiratory System Musculoskeletal system Neoplasms Genitourinary System Endocrine System Direct Costs of the 1 Leading Diagnostic Groups (Billions of dollars) (United States: 21). Source: Source: NHLBI.

75 Billions of Dollars Coronary Heart Disease Stroke Hypertensive Disease Heart Failure Estimated direct and indirect costs (in billions of dollars) of major cardiovascular diseases and stroke (United States: 21). Source: NHLBI.

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine The Heart of a Woman Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine American Heart Association Women, Heart Disease and Stroke

More information

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Content Introduction The number 1 killer in America Some statistics

More information

Why Do We Treat Obesity? Epidemiology

Why Do We Treat Obesity? Epidemiology Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population

More information

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY. OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY THE OREGON DEPARTMENT OF HUMAN SERVICES HEALTH SERVICES HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM www.healthoregon.org/hpcdp Contents

More information

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010 Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010 Content Introduction The number 1 killer in America Some statistics

More information

Texas Chronic Disease Burden Report. April Publication #E

Texas Chronic Disease Burden Report. April Publication #E Texas Chronic Disease Burden Report April 2010 Publication #E81-11194 Direction and Support Lauri Kalanges, MD, MPH Medical Director Health Promotion and Chronic Disease Prevention Section, Texas Department

More information

The Burden Report: Cardiovascular Disease & Stroke in Texas

The Burden Report: Cardiovascular Disease & Stroke in Texas The Burden Report: Cardiovascular Disease & Stroke in Texas Texas Cardiovascular Health and Wellness Program www.dshs.state.tx.us/wellness Texas Council on Cardiovascular Disease and Stroke www.texascvdcouncil.org

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

How do we define ethnic healthcare disparities? Ethnic Disparity. Cardiovascular Disease in Asians: Are Asians at Increased Risk?

How do we define ethnic healthcare disparities? Ethnic Disparity. Cardiovascular Disease in Asians: Are Asians at Increased Risk? Cardiovascular Disease in Asians: Are Asians at Increased Risk? November 17, 2007 Gordon L. Fung, MD, MPH, PhD, FACC, FAHA, FACP Director, Asian Heart & Vascular Center Clinical Professor of Medicine UCSF

More information

Heart Disease and Stroke Statistics 2018 At-a-Glance

Heart Disease and Stroke Statistics 2018 At-a-Glance Heart Disease and Stroke Statistics 2018 At-a-Glance Here are a few key statistics about heart disease, stroke, other cardiovascular diseases and their risk factors, in addition to commonly cited statistics

More information

Heart Disease and Stroke Statistics-2019 At-a-Glance

Heart Disease and Stroke Statistics-2019 At-a-Glance Heart Disease and Stroke Statistics-2019 At-a-Glance This document contains a few key statistics about heart disease, stroke, other cardiovascular diseases and their risk factors, in addition to commonly

More information

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012 SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK

More information

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato Preventing Cardiovascular Disease Chapter 2 Cardiovascular Disease the leading cause of death in the U.S. 35.3% of all deaths

More information

Leading Causes of Death in US (2013-CDC):

Leading Causes of Death in US (2013-CDC): Leading Causes of Death in 1. Heart disease: 611,105 US (2013-CDC): 2. Cancer: 584,881 3. Chronic lower respiratory diseases (Emphysema and Chronic Bronchitis): 149,205 4. Accidents (unintentional injuries):

More information

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population! Myths, Heart Disease and the Latino Population Maria T. Vivaldi MD MGH Women s Heart Health Program Hispanics constitute 16.3 % of US population! 1 LEADING CAUSES OF DEATH IN LATINOS Heart disease is the

More information

Demographics and Health Data

Demographics and Health Data Demographics and Health Data Information for Local Planners City of Puyallup, WA Demographic Characteristics Environmental Health Division 3629 South D Street, Tacoma, WA 98418 (253) 798-6470 Table 1 presents

More information

Demographics and Health Data

Demographics and Health Data Demographics and Health Data Information for Local Planners City of Lakewood, WA Demographic Characteristics Environmental Health Division 3629 South D Street, Tacoma, WA 98418 (253) 798-6470 Table 1 presents

More information

The Muscatine Study Heart Health Survey

The Muscatine Study Heart Health Survey The Muscatine Study Heart Health Survey PARTICIPANT ID LABEL (include study ID, name, DOB, gender) Today s Date: - - (MM-DD-YYYY) Thank you for agreeing to participate in the International Childhood Cardiovascular

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

AHA Statistical Update

AHA Statistical Update AHA Statistical Update Heart Disease and Stroke Statistics 2006 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Writing Group Members Thomas

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Healthy Montgomery Obesity Work Group Montgomery County Obesity Profile July 19, 2012

Healthy Montgomery Obesity Work Group Montgomery County Obesity Profile July 19, 2012 Healthy Montgomery Obesity Work Group Montgomery County Obesity Profile July 19, 2012 Prepared by: Rachel Simpson, BS Colleen Ryan Smith, MPH Ruth Martin, MPH, MBA Hawa Barry, BS Executive Summary Over

More information

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313) University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,

More information

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health Cardiovascular Disease in Tennessee Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health Practical Strategies in Medication Adherence for Cardiac and Stroke

More information

The Burden of Cardiovascular Disease in North Carolina. Justus-Warren Heart Disease and Stroke Prevention Task Force April 11, 2018

The Burden of Cardiovascular Disease in North Carolina. Justus-Warren Heart Disease and Stroke Prevention Task Force April 11, 2018 The Burden of Cardiovascular Disease in North Carolina Justus-Warren Heart Disease and Stroke Prevention Task Force April 11, 2018 Purpose 1. To detail the burden of heart disease and stroke in North Carolina

More information

Prevenzione cardiovascolare e cambiamento degli stili di vita. Gian Franco Gensini

Prevenzione cardiovascolare e cambiamento degli stili di vita. Gian Franco Gensini Prevenzione cardiovascolare e cambiamento degli stili di vita Gian Franco Gensini Main causes of death worldwide at all ages (year:: 2005) 17.5 milion Preventing Chronic Diseases A vital investiment. WHO

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

The clinical and economic benefits of better treatment of adult Medicaid beneficiaries with diabetes

The clinical and economic benefits of better treatment of adult Medicaid beneficiaries with diabetes The clinical and economic benefits of better treatment of adult Medicaid beneficiaries with diabetes September, 2017 White paper Life Sciences IHS Markit Introduction Diabetes is one of the most prevalent

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

AHA Statistical Update

AHA Statistical Update AHA Statistical Update Heart Disease and Stroke Statistics 2008 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee WRITING GROUP MEMBERS Wayne Rosamond,

More information

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both direct and indirect and the projected burden of diabetes,

More information

Looking Toward State Health Assessment.

Looking Toward State Health Assessment. CONNECTICUT DEPARTMENT OF PUBLIC HEALTH Policy, Planning and Analysis. Looking Toward 2000 - State Health Assessment. Table of Contents Glossary Maps Appendices Publications Public Health Code PP&A Main

More information

Vascular Diseases. Overview: Selected Slides

Vascular Diseases. Overview: Selected Slides Vascular Diseases Overview: Selected Slides Total deaths and change in vascular death rates

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital

More information

40% minimum reduction from

40% minimum reduction from 160 Circulatory Disease Mortality Target: Death rates in England 1993-2006 Persons under 75 Death / 100,000 population A fall of 44% over 10 years 140 120 100 80 60 40 20 141.0 84.2 Immortality guaranteed

More information

A n aly tical m e t h o d s

A n aly tical m e t h o d s a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.

More information

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review

More information

10/21/2014. Disclosures. Introduction. Reasons for the Decline in Stroke Mortality: Implications for Hypertension and Risk Factor Management

10/21/2014. Disclosures. Introduction. Reasons for the Decline in Stroke Mortality: Implications for Hypertension and Risk Factor Management Reasons for the Decline in Stroke Mortality: Implications for Hypertension and Risk Factor Management Daniel T Lackland Disclosures Member of NHLBI Risk Assessment Workgroup Member of 2014 Hypertension

More information

OBESITY IN MISSOURI: IMPLICATIONS FOR HEALTH / FOOD POLICY

OBESITY IN MISSOURI: IMPLICATIONS FOR HEALTH / FOOD POLICY 1 OBESITY IN MISSOURI: IMPLICATIONS FOR HEALTH / FOOD POLICY Venkata Garikapaty, PhD, MPH Chief, Office of Epidemiology Missouri Department of Health and Senior Services 10/26/2017 Missouri Council for

More information

Health Risk Behaviors in the State of Michigan Behavioral Risk Factor Survey. 19th Annual Report

Health Risk Behaviors in the State of Michigan Behavioral Risk Factor Survey. 19th Annual Report Health Risk Behaviors in the State of Michigan 2005 Behavioral Risk Factor Survey 19th Annual Report 2005 Behavioral Risk Factor Survey Health Risk Behaviors in the State of Michigan www.michigan.gov/brfs

More information

The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics

The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics Michael H. Criqui MD, MPH Distinguished Professor and Chief, Division of Preventive Medicine Department of Family and Preventive

More information

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Cardiovascular Disease Prevention: Current Knowledge, Future Directions Cardiovascular Disease Prevention: Current Knowledge, Future Directions Daniel Levy, MD Director, Framingham Heart Study Professor of Medicine, Boston University School of Medicine Editor-in-Chief, Journal

More information

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution

More information

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida The 21 st Century Paradigm Shift: Prevention Rather Than Intervention for the Treatment of Stable CHD The Economic Burden of Cardiovascular Diseases Basil Margolis MD, FACC, FRCP Director, Preventive Cardiology

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive

More information

National Diabetes Fact Sheet, 2007

National Diabetes Fact Sheet, 2007 National Diabetes Fact Sheet, 2007 General Information What is diabetes? Diabetes is a group of diseases marked by high levels of blood glucose resulting from defects in insulin production, insulin action,

More information

Page down (pdf converstion error)

Page down (pdf converstion error) 1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999

More information

A Closer Look at Leading Causes of Death in Guilford County

A Closer Look at Leading Causes of Death in Guilford County 2015 GCDHHS Division of Public Health Data Brief A Closer Look at Leading Causes of Death in Guilford County Highlights Heart disease mortality rates declined 43% from 244.8 deaths per 100,000 in 1995

More information

What is hypertension?

What is hypertension? HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90

More information

Data Brief: Cardiovascular Diseases among American Indians and Alaska Natives in Washington State

Data Brief: Cardiovascular Diseases among American Indians and Alaska Natives in Washington State Data Brief: Cardiovascular Diseases among American Indians and Alaska Natives in Washington State Prepared by IDEA-NW, a project of the Northwest Portland Area Indian Health Board Indian Leadership for

More information

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised

More information

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular

More information

Women s Ischemia and cardiac rehabilitation

Women s Ischemia and cardiac rehabilitation Women s Ischemia and cardiac rehabilitation Dr. Pallavi Bellamkonda MD, FACC Financial Disclosures: None 1 Objectives Understanding the Unique presentations of Ischemic Disease in Women: Obstructive Coronary

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

CHD in Race & Ethnicity. Gettyimages.com

CHD in Race & Ethnicity. Gettyimages.com CHD in Race & Ethnicity Gettyimages.com Of all the forms of inequality, injustice in health care is the most inhumane. Martin Luther King, Jr. D e a t h s I n LEADING CAUSE OF DEATH FOR ALL MALES AND FEMALES

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING

More information

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:

More information

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System

More information

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

A Needs Assessment of Hypertension in Georgia

A Needs Assessment of Hypertension in Georgia A Needs Assessment of Hypertension in Georgia Faye Lopez Mercer University School of Medicine Marylen Rimando Mercer University School of Medicine Harshali Khapekar Mercer University School of Medicine

More information

Perceptions of Obesity Risk & Prevention in Chinese Americans

Perceptions of Obesity Risk & Prevention in Chinese Americans Perceptions of Obesity Risk & Prevention in Chinese Americans Dr. Doreen Liou Dr. Kathleen Bauer Montclair State University Department of Health & Nutrition Sciences Montclair, New Jersey Obesity is a

More information

Death, Illness, and Injury

Death, Illness, and Injury Death, Illness, and Injury Death (Mortality) In 2013, a total of 3,396 Hamilton County residents died. Of those deaths, persons over 85 years of age accounted for 30%, followed by the 75 to 84 age group

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Depok-Indonesia STEPS Survey 2003

Depok-Indonesia STEPS Survey 2003 The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural

More information

Sherri Homan, RN, PhD Public Health Epidemiologist March 2009 Update

Sherri Homan, RN, PhD Public Health Epidemiologist March 2009 Update Sherri Homan, RN, PhD Public Health Epidemiologist March 2009 Update Report Authors Wayne Schramm Kris Kummerfeld Contributors Anita Berwanger Linda Powell Karen Connell Lisa Britt Andy Hunter Joseph Stockbauer

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL DEFINITION OF A SCREENING TEST TESTING FOR A DISEASE OR CONDITION IN ASYMPTOMATIC PERSONS TO IDENTIFY THE CONDITION BEFORE IT MANIFESTS

More information

Maintaining Healthy Weight in Childhood: The influence of Biology, Development and Psychology

Maintaining Healthy Weight in Childhood: The influence of Biology, Development and Psychology Maintaining Healthy Weight in Childhood: The influence of Biology, Development and Psychology Maintaining a Healthy Weight in Biology Development Psychology Childhood And a word about the Toxic Environment

More information

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center THE END! CHANGABLE Blood pressure Diabetes Mellitus Hyperlipidemia Atrial fibrillation Nicotine Drug abuse Life style NOT CHANGABLE

More information

Risk Factors for NCDs

Risk Factors for NCDs Risk Factors for NCDs Objectives: Define selected risk factors such as; tobacco use, diet, nutrition, physical activity, obesity, and overweight Present the epidemiology and significance of the risk factors

More information

Health Concern. Obesity Guilford County Department of Public Health Community Health Assessment

Health Concern. Obesity Guilford County Department of Public Health Community Health Assessment 2012-2013 Guilford County Department of Public Health Community Health Assessment 10 Health Concern The leading causes of death in Guilford County are chronic degenerative diseases, especially cancer and

More information

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN 1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification

More information

Chronic Disease Challenges and Solutions

Chronic Disease Challenges and Solutions Chronic Disease Challenges and Solutions Janet Collins, PhD Director, Division of Nutrition, Physical Activity and Obesity, CDC Council of State Governments Kansas City, MO September 18, 2013 Centers for

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

Trends in Pneumonia and Influenza Morbidity and Mortality

Trends in Pneumonia and Influenza Morbidity and Mortality Trends in Pneumonia and Influenza Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Health Education Division November 2015 Page intentionally left blank Introduction

More information

Dr. Suzanne Steinbaum Director, Women and Heart Disease Lenox Hill Hospital New York

Dr. Suzanne Steinbaum Director, Women and Heart Disease Lenox Hill Hospital New York Dr. Suzanne Steinbaum Director, Women and Heart Disease Lenox Hill Hospital New York 500,000 400,000 398,563 432,709 Deaths 300,000 200,000 290,069 269,819 100,000 78,941 59,260 36,006 65,323 51,281 42,658

More information

10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None

10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH None 1 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here?

More information

Blood Pressure Guidelines: Using Science for Integrated Public Health and Clinical Care Systems

Blood Pressure Guidelines: Using Science for Integrated Public Health and Clinical Care Systems Blood Pressure Guidelines: Using Science for Integrated Public Health and Clinical Care Systems April 11, 2014; 1pm-2pm EST Presenter Eduardo Sanchez, MD, MPH, FAAFP Deputy Chief Medical Officer, American

More information

Evaluation and Treatment of Childhood Obesity

Evaluation and Treatment of Childhood Obesity Evaluation and Treatment of Childhood Obesity Stephen R. Daniels, MD, PhD Department of Pediatrics University of Colorado School of Medicine and Children s Hospital Colorado In 1953, Morris et al compared

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

National Diabetes Fact Sheet, 2011

National Diabetes Fact Sheet, 2011 National Diabetes Fact Sheet, 2011 FAST FACTS ON DIABETES Diabetes affects 25.8 million people 8.3% of the U.S. population DIAGNOSED 18.8 million people UNDIAGNOSED 7.0 million people All ages, 2010 Citation

More information

Colorado s Progress toward Year 2000 Objectives

Colorado s Progress toward Year 2000 Objectives Colorado s Progress toward Year Objectives An update from the Survey Research Unit No. 26 November 1998 Two major roles of Public Health are to reduce preventable death and disability and to enhance quality

More information

2013 Hypertension Measure Group Patient Visit Form

2013 Hypertension Measure Group Patient Visit Form Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part

More information

Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014.

Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management None Disclosures Arthur Agatston Conceptual Approach to CAD Risk Devereux Circulation, 1993 1 Age Obesity Family Hx Diabetes

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease AMWA is a leader in its dedication to educating all physicians and their patients about heart disease,

More information

CARDIOMETABOLIC SYNDROME

CARDIOMETABOLIC SYNDROME CARDIOMETABOLIC SYNDROME Prof. Gerald Yonga FESC, FACC Dept of Medicine, Aga Khan University East Africa Introduction Years after the term metabolic syndrome was first coined, controversy continues over

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu

More information

Healthy People 2020 Summary of Objectives. Heart Disease and Stroke

Healthy People 2020 Summary of Objectives. Heart Disease and Stroke Healthy People 2020 Summary of Objectives Heart Disease and Stroke Number HDS 1 HDS 2 HDS 3 HDS 4 HDS 5 HDS 6 HDS 7 HDS 8 HDS 9 HDS 10 HDS 11 HDS 12 HDS 13 HDS 14 HDS-15 HDS 16 HDS 17 HDS 18 HDS 19 HDS

More information

Community Health Needs Assessment for UI Health Hospital & Clinics

Community Health Needs Assessment for UI Health Hospital & Clinics Community Health Needs Assessment for UI Health Hospital & Clinics Office of the Vice Chancellor for Health Affairs Community Engagement & Neighborhood Health Health Policy & Strategy Population Health

More information

Arizona Cardiovascular Disease State Plan

Arizona Cardiovascular Disease State Plan Arizona Cardiovascular Disease State Plan Coming together is a beginning, staying together is progress, and working together is success. - Henry Ford 1 Acknowledgements TRUST Commission We would like to

More information